Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators.

JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.

PMID:
24711047
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.

Moonen AJ, Wijers A, Leentjens AF, Christine CW, Factor SA, Juncos J, Lyness JM, Marsh L, Panisset M, Pfeiffer R, Rottenberg D, Serrano Ramos C, Shulman L, Singer C, Slevin J, McDonald W, Auinger P, Richard IH.

Parkinsonism Relat Disord. 2014 Jun;20(6):644-6. doi: 10.1016/j.parkreldis.2014.02.025. Epub 2014 Mar 18.

PMID:
24679737
[PubMed - in process]
3.

The role of electroconvulsive and neuromodulation therapies in the treatment of geriatric depression.

Riva-Posse P, Hermida AP, McDonald WM.

Psychiatr Clin North Am. 2013 Dec;36(4):607-30. doi: 10.1016/j.psc.2013.08.007. Epub 2013 Oct 6. Review.

PMID:
24229660
[PubMed - indexed for MEDLINE]
4.

Psychiatric comorbidities in dystonia: emerging concepts.

Zurowski M, McDonald WM, Fox S, Marsh L.

Mov Disord. 2013 Jun 15;28(7):914-20. doi: 10.1002/mds.25501. Review.

PMID:
23893448
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.

Borckardt JJ, Nahas ZH, Teal J, Lisanby SH, McDonald WM, Avery D, Durkalski V, Pavlicova M, Long JM, Sackeim HA, George MS.

Brain Stimul. 2013 Nov;6(6):925-8. doi: 10.1016/j.brs.2013.04.009. Epub 2013 May 21.

PMID:
23769413
[PubMed - indexed for MEDLINE]
6.

Web-based involuntary-commitment educational project for emergency medicine residents: an interdepartmental quality initiative.

Vahabzadeh A, Wittenauer J, McDonald WM.

Acad Psychiatry. 2013 Jan 1;37(1):64-5. doi: 10.1176/appi.ap.12050097. No abstract available.

PMID:
23338880
[PubMed - indexed for MEDLINE]
7.

Physicians' warnings for unfit drivers and risk of road crashes.

Vahabzadeh A, McDonald WM.

N Engl J Med. 2013 Jan 3;368(1):86-7. doi: 10.1056/NEJMc1212928#SA1. No abstract available.

PMID:
23281993
[PubMed - indexed for MEDLINE]
8.

The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Hermida AP, McDonald WM, Steenland K, Levey A.

Expert Rev Neurother. 2012 Nov;12(11):1339-50. doi: 10.1586/ern.12.127. Review.

PMID:
23234395
[PubMed - indexed for MEDLINE]
9.

New insights from China on the efficacy of ECT in schizophrenia.

McDonald WM.

J ECT. 2012 Dec;28(4):203-4. doi: 10.1097/YCT.0b013e31826563ef. No abstract available.

PMID:
23164724
[PubMed - indexed for MEDLINE]
10.

Electroconvulsive therapy in China (II): research on the technical parameters and mechanism of action.

Ren YP, Jiang W, Cotes RO, Tang YL, Ma X, McDonald WM.

J ECT. 2012 Dec;28(4):213-8. doi: 10.1097/YCT.0b013e3182617ef9. Review.

PMID:
23041767
[PubMed - indexed for MEDLINE]
11.

Changes in heart rate variability of depressed patients after electroconvulsive therapy.

Royster EB, Trimble LM, Cotsonis G, Schmotzer B, Manatunga A, Rushing NN, Pagnoni G, Auyeung SF, Brown AR, Schoenbeck J, Murthy S, McDonald WM, Musselman DL.

Cardiovasc Psychiatry Neurol. 2012;2012:794043. doi: 10.1155/2012/794043. Epub 2012 Aug 27.

PMID:
22966422
[PubMed]
Free PMC Article
12.

Electrophilic adduction of ubiquitin activating enzyme E1 by N,N-diethyldithiocarbamate inhibits ubiquitin activation and is accompanied by striatal injury in the rat.

Viquez OM, Caito SW, McDonald WH, Friedman DB, Valentine WM.

Chem Res Toxicol. 2012 Nov 19;25(11):2310-21. doi: 10.1021/tx300198h. Epub 2012 Aug 22.

PMID:
22874009
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Electroconvulsive therapy in China: clinical practice and research on efficacy.

Tang YL, Jiang W, Ren YP, Ma X, Cotes RO, McDonald WM.

J ECT. 2012 Dec;28(4):206-12. doi: 10.1097/YCT.0b013e31825957b1. Review.

PMID:
22801297
[PubMed - indexed for MEDLINE]
14.

Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.

Mantovani A, Pavlicova M, Avery D, Nahas Z, McDonald WM, Wajdik CD, Holtzheimer PE 3rd, George MS, Sackeim HA, Lisanby SH.

Depress Anxiety. 2012 Oct;29(10):883-90. doi: 10.1002/da.21967. Epub 2012 Jun 11.

PMID:
22689290
[PubMed - indexed for MEDLINE]
15.

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, Panisset M, Christine CW, Jiang W, Singer C, Horn S, Pfeiffer R, Rottenberg D, Slevin J, Elmer L, Press D, Hyson HC, McDonald W; SAD-PD Study Group.

Neurology. 2012 Apr 17;78(16):1229-36. doi: 10.1212/WNL.0b013e3182516244. Epub 2012 Apr 11.

PMID:
22496199
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial.

Johnson KA, Baig M, Ramsey D, Lisanby SH, Avery D, McDonald WM, Li X, Bernhardt ER, Haynor DR, Holtzheimer PE 3rd, Sackeim HA, George MS, Nahas Z.

Brain Stimul. 2013 Mar;6(2):108-17. doi: 10.1016/j.brs.2012.02.003. Epub 2012 Mar 14.

PMID:
22465743
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Defining neurocognitive disorders.

McDonald WM.

Am J Geriatr Psychiatry. 2011 Nov;19(11):909-14. doi: 10.1097/JGP.0b013e31823497c7. No abstract available.

PMID:
21975640
[PubMed - indexed for MEDLINE]
18.

Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression.

McDonald WM, Durkalski V, Ball ER, Holtzheimer PE, Pavlicova M, Lisanby SH, Avery D, Anderson BS, Nahas Z, Zarkowski P, Sackeim HA, George MS.

Depress Anxiety. 2011 Nov;28(11):973-80. doi: 10.1002/da.20885. Epub 2011 Sep 2.

PMID:
21898711
[PubMed - indexed for MEDLINE]
19.

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.

Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF.

Brain Stimul. 2010 Oct;3(4):187-99. doi: 10.1016/j.brs.2010.07.003. Epub 2010 Aug 11.

PMID:
20965447
[PubMed - indexed for MEDLINE]
20.

Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression.

Holtzheimer PE 3rd, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G, Epstein CM.

Depress Anxiety. 2010 Oct;27(10):960-3. doi: 10.1002/da.20731.

PMID:
20734360
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk